Helicobacter pylori stimulates host vascular endothelial growth factor-A (vegf-A) gene expression via MEK/ERK-dependent activation of Sp1 and Sp3.

scientific article published on 3 November 2003

Helicobacter pylori stimulates host vascular endothelial growth factor-A (vegf-A) gene expression via MEK/ERK-dependent activation of Sp1 and Sp3. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1096/FJ.03-0055FJE
P698PubMed publication ID14597566
P5875ResearchGate publication ID9025851

P50authorThomas F. MeyerQ2423758
Silja WesslerQ37841647
Christian WunderQ40393802
Anna K. WalduckQ51032401
Thorsten CramerQ52902687
P2093author name stringMatthias Weber
Georgia Schäfer
Ernestina Schipani
Bertram Wiedenmann
Michael Naumann
Wolfgang Kemmner
Mathias Z Strowski
Stefan Jüttner
Michael Höcker
Thomas Jöns
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectHelicobacter pyloriQ180556
P304page(s)218-220
P577publication date2003-11-03
P1433published inFASEB JournalQ520194
P1476titleHelicobacter pylori stimulates host vascular endothelial growth factor-A (vegf-A) gene expression via MEK/ERK-dependent activation of Sp1 and Sp3.
P478volume18

Reverse relations

cites work (P2860)
Q33737879Bacterial oncogenesis in the colon
Q93200186CHAF1A interacts with TCF4 to promote gastric carcinogenesis via upregulation of c-MYC and CCND1 expression
Q41695649Expression levels of vascular endothelial growth factors a and C in patients with peptic ulcers and gastric cancer
Q51922958Expression profiles of nestin in vascular smooth muscle cells in vivo and in vitro.
Q40226038H pylori stimulates proliferation of gastric cancer cells through activating mitogen-activated protein kinase cascade
Q37230001Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine
Q39630728Helicobacter pylori Induction of the Gastrin Promoter Through GC‐Rich DNA Elements
Q91714406Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study
Q36023196Helicobacter pylori promotes angiogenesis depending on Wnt/beta-catenin-mediated vascular endothelial growth factor via the cyclooxygenase-2 pathway in gastric cancer
Q39937536Helicobacter pylori protein HP0175 transactivates epidermal growth factor receptor through TLR4 in gastric epithelial cells
Q34221649Histone demethylase RBP2 induced by Helicobactor Pylori CagA participates in the malignant transformation of gastric epithelial cells
Q39660448Implication of the ERK Pathway on the Post-transcriptional Regulation of VEGF mRNA Stability
Q64064573Increased LIGHT expression and activation of non-canonical NF-κB are observed in gastric lesions of MyD88-deficient mice upon Helicobacter felis infection
Q39204794NF-κB Signaling in Gastric Cancer.
Q41831890Novel action of gastric proton pump inhibitor on suppression of Helicobacter pylori induced angiogenesis
Q24295052Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis
Q42138610The Anti-inflammatory Effects of Acidic Polysaccharide from Artemisia capillaris on Helicobacter pylori Infection
Q31036498The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization
Q36977057The role of Sp1 in IL-1beta and H. pylori-mediated regulation of H,K-ATPase gene transcription
Q52877812Transcription of the vascular endothelial growth factor receptor-3 (VEGFR3) gene is regulated by the zinc finger proteins Sp1 and Sp3 and is under epigenetic control: transcription of vascular endothelial growth factor receptor 3.
Q36384880VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes
Q40978388Withaferin A inhibits the proliferation of gastric cancer cells by inducing G2/M cell cycle arrest and apoptosis
Q37493227YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma
Q37122693YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models.

Search more.